BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27941040)

  • 1. Genetic predisposition to prostate cancer.
    Benafif S; Eeles R
    Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
    Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
    Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.
    Orozco G; Goh CL; Al Olama AA; Benlloch-Garcia S; Govindasami K; Guy M; Muir KR; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Kote-Jarai Z; Easton DF; Eyre S; Eeles RA
    BJU Int; 2013 Jun; 111(7):1148-55. PubMed ID: 22985493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.
    Saunders EJ; Dadaev T; Leongamornlert DA; Al Olama AA; Benlloch S; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pasayan N; Khaw KT; Stanford JL; Blot WJ; Thibodeau SN; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Teixeira MR; Pandha H; Govindasami K; Muir K; ; ; ; Easton DF; Eeles RA; Kote-Jarai Z
    Br J Cancer; 2016 Apr; 114(8):945-52. PubMed ID: 26964030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline copy number variation analysis in Finnish families with hereditary prostate cancer.
    Laitinen VH; Akinrinade O; Rantapero T; Tammela TL; Wahlfors T; Schleutker J
    Prostate; 2016 Feb; 76(3):316-24. PubMed ID: 26552734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.
    Castro E; Mikropoulos C; Bancroft EK; Dadaev T; Goh C; Taylor N; Saunders E; Borley N; Keating D; Page EC; Saya S; Hazell S; Livni N; deSouza N; Neal D; Hamdy FC; Kumar P; Antoniou AC; Kote-Jarai Z; ; Eeles RA
    Oncologist; 2016 Jun; 21(6):716-22. PubMed ID: 27151655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic predisposition to prostate cancer: an update.
    Ni Raghallaigh H; Eeles R
    Fam Cancer; 2022 Jan; 21(1):101-114. PubMed ID: 33486571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer screening in BRCA and Lynch syndrome mutation carriers.
    Castro E; Goh CL; Eeles RA
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer.
    Kote-Jarai Z; Jugurnauth S; Mulholland S; Leongamornlert DA; Guy M; Edwards S; Tymrakiewitcz M; O'Brien L; Hall A; Wilkinson R; Al Olama AA; Morrison J; Muir K; Neal D; Donovan J; Hamdy F; Easton DF; Eeles R; ;
    Br J Cancer; 2009 Jan; 100(2):426-30. PubMed ID: 19127258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of prostate cancer and its utility in treatment and screening.
    Benafif S; Ni Raghallaigh H; McHugh J; Eeles R
    Adv Genet; 2021; 108():147-199. PubMed ID: 34844712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare germline genetic variants and risk of aggressive prostate cancer.
    Nguyen-Dumont T; MacInnis RJ; Steen JA; Theys D; Tsimiklis H; Hammet F; Mahmoodi M; Pope BJ; Park DJ; Mahmood K; Severi G; Bolton D; Milne RL; Giles GG; Southey MC
    Int J Cancer; 2020 Oct; 147(8):2142-2149. PubMed ID: 32338768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.
    Kim S; Shin C; Jee SH
    Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction.
    Agalliu I; Wang Z; Wang T; Dunn A; Parikh H; Myers T; Burk RD; Amundadottir L
    PLoS One; 2013; 8(4):e60083. PubMed ID: 23573233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study.
    Hishida A; Nakatochi M; Tamura T; Nagayoshi M; Okada R; Kubo Y; Tsukamoto M; Kadomatsu Y; Suzuki S; Nishiyama T; Kuriyama N; Watanabe I; Takezaki T; Nishimoto D; Kuriki K; Arisawa K; Katsuura-Kamano S; Mikami H; Kusakabe M; Oze I; Koyanagi YN; Nakamura Y; Kadota A; Shimanoe C; Tanaka K; Ikezaki H; Murata M; Kubo M; Momozawa Y; Takeuchi K; Wakai K;
    Nagoya J Med Sci; 2021 Feb; 83(1):183-194. PubMed ID: 33727749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genome-wide association study of prostate cancer in Latinos.
    Du Z; Hopp H; Ingles SA; Huff C; Sheng X; Weaver B; Stern M; Hoffmann TJ; John EM; Van Den Eeden SK; Strom S; Leach RJ; Thompson IM; Witte JS; Conti DV; Haiman CA
    Int J Cancer; 2020 Apr; 146(7):1819-1826. PubMed ID: 31226226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript.
    Kote-Jarai Z; Amin Al Olama A; Leongamornlert D; Tymrakiewicz M; Saunders E; Guy M; Giles GG; Severi G; Southey M; Hopper JL; Sit KC; Harris JM; Batra J; Spurdle AB; Clements JA; Hamdy F; Neal D; Donovan J; Muir K; Pharoah PD; Chanock SJ; Brown N; Benlloch S; Castro E; Mahmud N; O'Brien L; Hall A; Sawyer E; Wilkinson R; Easton DF; Eeles RA
    Hum Genet; 2011 Jun; 129(6):687-94. PubMed ID: 21465221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer.
    Lee DJ; Hausler R; Le AN; Kelly G; Powers J; Ding J; Feld E; Desai H; Morrison C; Doucette A; Gabriel P; Genetics Center R; Judy RL; Weaver J; Kember R; Damrauer SM; Rader DJ; Domchek SM; Narayan V; Schwartz LE; Maxwell KN
    Eur Urol; 2022 Jun; 81(6):559-567. PubMed ID: 34711450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.
    Maia S; Cardoso M; Paulo P; Pinheiro M; Pinto P; Santos C; Pinto C; Peixoto A; Henrique R; Teixeira MR
    Fam Cancer; 2016 Jan; 15(1):111-21. PubMed ID: 26289772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Cancer Germline Variations and Implications for Screening and Treatment.
    Dias A; Kote-Jarai Z; Mikropoulos C; Eeles R
    Cold Spring Harb Perspect Med; 2018 Sep; 8(9):. PubMed ID: 29101112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
    Wiklund F; Zheng SL; Sun J; Adami HO; Lilja H; Hsu FC; Stattin P; Adolfsson J; Cramer SD; Duggan D; Carpten JD; Chang BL; Isaacs WB; Grönberg H; Xu J
    Prostate; 2009 Mar; 69(4):419-27. PubMed ID: 19116992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.